Binhui Xie

1.2k total citations · 1 hit paper
27 papers, 747 citations indexed

About

Binhui Xie is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Binhui Xie has authored 27 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Binhui Xie's work include RNA modifications and cancer (9 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Binhui Xie is often cited by papers focused on RNA modifications and cancer (9 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Binhui Xie collaborates with scholars based in China, United Kingdom and Hong Kong. Binhui Xie's co-authors include Heping Li, Xinggang Wang, Yuxin Fang, Tiejun Huang, Ledell Wu, Quan Sun, Yue Cao, Wen Wang, Xinlong Wang and Xiaonong Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Binhui Xie

26 papers receiving 732 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EVA: Exploring the Limits of Masked Visual Representation Learning at Scale

2023 239 citations Binhui Xie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Binhui Xie China	12	382	275	157	102	79	27	747
Xiuhui Chen China	15	532 1.4×	298 1.1×	193 1.2×	55 0.5×	54 0.7×	35	914
Jinfeng Bai China	21	546 1.4×	193 0.7×	320 2.0×	215 2.1×	168 2.1×	52	1.2k
John Lai Australia	17	386 1.0×	162 0.6×	151 1.0×	84 0.8×	168 2.1×	44	1.0k
Haoran Wei China	15	316 0.8×	178 0.6×	360 2.3×	100 1.0×	58 0.7×	37	908
Xiangyun Ye China	16	473 1.2×	163 0.6×	137 0.9×	27 0.3×	120 1.5×	36	811
Ke Yuan China	13	254 0.7×	162 0.6×	36 0.2×	94 0.9×	87 1.1×	52	615
Xin Luo China	13	358 0.9×	201 0.7×	186 1.2×	171 1.7×	48 0.6×	43	791
Chuandong Cheng China	13	372 1.0×	228 0.8×	45 0.3×	50 0.5×	95 1.2×	23	604
Xinmin Fan China	15	362 0.9×	215 0.8×	38 0.2×	68 0.7×	40 0.5×	29	587
Boxiang Zhang China	17	410 1.1×	254 0.9×	54 0.3×	48 0.5×	145 1.8×	60	694

Countries citing papers authored by Binhui Xie

Since Specialization

Citations

This map shows the geographic impact of Binhui Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binhui Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binhui Xie more than expected).

Fields of papers citing papers by Binhui Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binhui Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binhui Xie. The network helps show where Binhui Xie may publish in the future.

Co-authorship network of co-authors of Binhui Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Binhui Xie. A scholar is included among the top collaborators of Binhui Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binhui Xie. Binhui Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Rui, Meng Wang, Yunyun Xiao, et al.. (2025). POLRMT enhances lenvatinib resistance in hepatocellular carcinoma cells by maintaining mitochondrial ATP production. Life Sciences. 379. 123876–123876.

Xie, Binhui, et al.. (2024). Downregulation of SSR2 Enhances Hepatocellular Carcinoma Cisplatin Sensitivity via the Hippo Pathway. Frontiers in Bioscience-Landmark. 29(8). 299–299. 2 indexed citations

Zhang, Jianhong, et al.. (2024). Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation. Frontiers in Pharmacology. 15. 1360974–1360974. 4 indexed citations

Zeng, Fan‐Lin, Xing Xie, Jianhong Zhang, et al.. (2023). LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination. Neoplasma. 70(3). 361–374. 9 indexed citations

Xie, Binhui, et al.. (2023). VBLC: Visibility Boosting and Logit-Constraint Learning for Domain Adaptive Semantic Segmentation under Adverse Conditions. Proceedings of the AAAI Conference on Artificial Intelligence. 37(7). 8605–8613. 8 indexed citations

Xie, Binhui, Zhenxian Zhao, Jie Hu, et al.. (2023). STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 11(1). 26–26. 2 indexed citations

Xie, Binhui, Rong Ye, Jinrong Zhu, et al.. (2023). Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells. Oncogenesis. 12(1). 13–13. 9 indexed citations

Xie, Binhui, et al.. (2023). Elevated FAM134B expression induces radiation-sensitive in hepatocellular carcinoma. BMC Cancer. 23(1). 671–671. 1 indexed citations

Xie, Binhui, et al.. (2023). SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF‐κB Signaling Pathway. BioMed Research International. 2023(1). 7518744–7518744. 2 indexed citations

10.

Li, Heping, et al.. (2022). LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining β‐Catenin in the Nucleus to Augment Wnt Signaling. BioMed Research International. 2022(1). 9631036–9631036. 6 indexed citations

11.

Wang, Xiaoqing, et al.. (2022). BCAT1, as a prognostic factor for HCC, can promote the development of liver cancer through activation of the AKT signaling pathway and EMT. Journal of Molecular Histology. 54(1). 25–39. 15 indexed citations

12.

Xie, Binhui, et al.. (2022). Metastasis to the Pancreas From Ductal Carcinoma In Situ of Breast Cancer: A Case Report and Review of Literature.. PubMed. 28(6). 150–155. 2 indexed citations

13.

Zhang, Jianhong, et al.. (2021). Amplification of DDR2 mediates sorafenib resistance through NF‐κB/c‐Rel signaling in hepatocellular carcinoma. Cell Biology International. 45(9). 1906–1916. 11 indexed citations

14.

Tan, Guosheng, Binhui Xie, Na Yu, et al.. (2021). TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway. International Journal of Clinical Oncology. 26(3). 532–542. 18 indexed citations

15.

Wang, Yu, Binhui Xie, Weihao Lin, et al.. (2019). Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2. Oncogene. 38(25). 4948–4961. 54 indexed citations

16.

Yang, Qing, Binhui Xie, Hui Tang, et al.. (2019). Minichromosome maintenance 3 promotes hepatocellular carcinoma radioresistance by activating the NF-κB pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 263–263. 33 indexed citations

17.

Zhang, Bing, Rui‐Xi Hua, William Tai, et al.. (2015). URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway. BMC Cancer. 15(1). 368–368. 18 indexed citations

18.

Xie, Binhui, et al.. (2015). ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling. International Journal of Oncology. 46(5). 2057–2066. 29 indexed citations

19.

Xie, Binhui, Weihao Lin, Junming Ye, et al.. (2015). DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1. Journal of Experimental & Clinical Cancer Research. 34(1). 101–101. 63 indexed citations

20.

Wan, Daiwei, Songbing He, Binhui Xie, et al.. (2013). Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers. Medical Oncology. 30(1). 378–378. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact